Destiny Wealth Partners’s Elevance Health ELV Stock Holding History

Destiny Wealth Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-110	Closed	-$32.2K	–	422
2026 Q1	$32.2K	Buy	+110	New	+$36.2K	﹤0.01%	530
2023 Q1	–	Sell	-51	Closed	-$26.2K	–	312
2022 Q4	$26.2K	Sell	51 -93	-65%	-$47.2K	0.01%	366
2022 Q3	$65K	Hold	144	–	–	0.01%	255
2022 Q2	$69K	Buy	144 +75	+109%	+$37.1K	0.02%	255
2022 Q1	$34K	Hold	69	–	–	0.01%	350
2021 Q4	$32K	Hold	69	–	–	0.01%	363
2021 Q3	$26K	Buy	+69	New	+$26.2K	0.01%	355
2021 Q2	–	Sell	-69	Closed	-$25K	–	274
2021 Q1	$25K	Sell	69 -61	-47%	-$19.6K	0.01%	341
2020 Q4	$42K	Buy	+130	New	+$39.9K	0.01%	301

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Destiny Wealth Partners's ELV Position: Q2 2026 in Review

Destiny Wealth Partners sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 110 shares — an estimated $32.2K sold.

Destiny Wealth Partners first reported a position in ELV in Q4 2020 and held it in 9 quarters. The position peaked at $69K in Q2 2022. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Destiny Wealth Partners reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
Destiny Wealth Partners sold 110 Elevance Health shares in Q2 2026, an estimated $32.2K.
Destiny Wealth Partners first reported a position in Elevance Health in Q4 2020 and held it in 9 quarters.
Destiny Wealth Partners's Elevance Health position peaked at $69K in Q2 2022.
1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Destiny Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.